Gables Capital Management Inc. Pfizer Inc Transaction History

Gables Capital Management Inc.

$228 Million
Q3 2025

A detailed history of Gables Capital Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Gables Capital Management Inc. holds 36,111 shares of PFE stock, worth $905,663. This represents 0.4% of its overall portfolio holdings.

Number of Shares

36,111

Previous 41,252 12.46%

Holding current value

$905,663

Previous $999,000 7.91%

% of portfolio

0.4%

Previous 0.48%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$23.29 - $25.88 $119,733 - $133,049	-5,141 Reduced 12.46%	36,111 $920,000
Q2 2025 Jul 30, 2025	SELL	$21.59 - $24.84 $170,561 - $196,236	-7,900 Reduced 16.07%	41,252 $999,000
Q1 2025 May 08, 2025	BUY	$25.01 - $27.13 $20,008 - $21,704	800 Added 1.65%	49,152 $1.25 Million
Q4 2024 Feb 07, 2025	BUY	$24.8 - $30.19 $3,720 - $4,528	150 Added 0.31%	48,352 $1.28 Million
Q3 2024 Oct 24, 2024	BUY	$27.7 - $31.39 $112,157 - $127,098	4,049 Added 9.17%	48,202 $1.39 Million
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $99,145 - $116,180	3,925 Added 9.76%	44,153 $1.24 Million
Q1 2024 May 03, 2024	SELL	$25.89 - $29.73 $31,715 - $36,419	-1,225 Reduced 2.96%	40,228 $1.12 Million
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $40,501 - $52,607	-1,550 Reduced 3.6%	41,453 $1.19 Million
Q3 2023 Nov 02, 2023	SELL	$32.09 - $37.51 $99,479 - $116,281	-3,100 Reduced 6.72%	43,003 $1.43 Million
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $1,805 - $2,089	-50 Reduced 0.11%	46,103 $1.69 Million
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $22,962 - $29,975	-550 Reduced 1.18%	46,153 $2.37 Million
Q3 2022 Oct 31, 2022	BUY	$43.76 - $53.42 $2,188 - $2,671	50 Added 0.11%	46,703 $2.04 Million
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $20,938 - $24,826	-450 Reduced 0.96%	46,653 $2.45 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $187,575 - $232,429	-4,100 Reduced 8.01%	47,103 $2.44 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $44,419 - $65,843	1,075 Added 2.14%	51,203 $3.02 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $7,850 - $10,084	-200 Reduced 0.4%	50,128 $2.16 Million
Q2 2021 Aug 03, 2021	SELL	$35.91 - $40.68 $749,154 - $848,666	-20,862 Reduced 29.3%	50,328 $1.97 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $16,745 - $18,885	-500 Reduced 0.7%	71,190 $2.58 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $41,837 - $53,200	1,250 Added 1.77%	71,690 $2.64 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $78,581 - $92,193	2,475 Added 3.64%	70,440 $2.59 Million
Q2 2020 Jul 30, 2020	BUY	$30.12 - $36.54 $19,035 - $23,093	632 Added 0.94%	67,965 $2.22 Million
Q1 2020 May 07, 2020	BUY	$27.03 - $38.62 $57,249 - $81,797	2,118 Added 3.25%	67,333 $2.2 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $32,920 - $37,360	1,000 Added 1.56%	65,215 $2.56 Million
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $48,735 - $63,195	1,500 Added 2.39%	64,215 $2.31 Million
Q2 2019 Jul 31, 2019	BUY	$36.98 - $41.52 $3,697 - $4,152	100 Added 0.16%	62,715 $2.72 Million
Q1 2019 Apr 30, 2019	SELL	$37.5 - $41.2 $47,812 - $52,530	-1,275 Reduced 2.0%	62,615 $2.66 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $50,011 - $57,018	-1,300 Reduced 1.99%	63,890 $2.79 Million
Q3 2018 Nov 05, 2018	SELL	$34.47 - $41.81 $27,576 - $33,448	-800 Reduced 1.21%	65,190 $0
Q2 2018 Aug 03, 2018	BUY	$32.98 - $35.16 $49,700 - $52,986	1,507 Added 2.34%	65,990 $2.38 Million
Q1 2018 May 17, 2018	BUY	$31.91 - $37.02 $2.06 Million - $2.39 Million	64,483 New	64,483 $2.29 Million

Others Institutions Holding PFE

# of Institutions

3,353

Shares Held

3.57B

Call Options Held

87.2M

Put Options Held

106M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.

Account

Gables Capital Management Inc. Pfizer Inc Transaction History